Serine

Products in Health Canada’s databases that list Serine as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.

Drug products: 81; 24 authorized now
Natural health products: 0; 0 active licences
Notices of Compliance: 62
Products in all: 81

Drug products

Authorized products first.

Name	DIN	Status	Holder	Status since
20% PROSOL (1.02 G)	02141450	Marketed	Baxter Corporation	Jan 2015
CLINIMIX (300 MG)	02498448	Marketed	Baxter Corporation	Apr 2022
CLINIMIX (400 MG)	02498456	Marketed	Baxter Corporation	Apr 2023
CLINIMIX (400 MG)	02498464	Marketed	Baxter Corporation	Nov 2020
CLINIMIX E (250 MG)	02142384	Marketed	Baxter Corporation	Nov 2013
CLINIMIX E (400 MG)	02498413	Marketed	Baxter Corporation	Oct 2021
CLINIMIX E (400 MG)	02498421	Marketed	Baxter Corporation	Dec 2020
ESSEPNA (0.65 G)	02510324	Marketed	Fresenius Kabi Canada Ltd	Jan 2023
OLIMEL 5.7% (2.25 G)	02352540	Marketed	Baxter Corporation	Sep 2019
OLIMEL 5.7% E (2.25 G)	02352532	Marketed	Baxter Corporation	Jan 2011
OLIMEL 7.6% (3 G)	02477947	Marketed	Baxter Corporation	Jul 2021
OLIMEL 7.6% E (3 G)	02477955	Marketed	Baxter Corporation	Oct 2018
PERIOLIMEL 2.5% E (1.0 G)	02352494	Marketed	Baxter Corporation	Feb 2011
PRIMENE 10% (400 MG)	02236875	Marketed	Baxter Corporation	Dec 2014
SMOFKABIVEN (0.33 G)	02440695	Marketed	Fresenius Kabi Canada Ltd	Sep 2015
SMOFKABIVEN ELECTROLYTE FREE (0.33 G)	02440687	Marketed	Fresenius Kabi Canada Ltd	Sep 2015
SMOFKABIVEN EXTRA NITROGEN (0.43 G)	02501813	Marketed	Fresenius Kabi Canada Ltd	May 2021
SMOFKABIVEN EXTRA NITROGEN ELECTROLYTE FREE (0.43 G)	02501775	Marketed	Fresenius Kabi Canada Ltd	Jul 2021
SMOFKABIVEN PERIPHERAL (210 MG)	02456206	Marketed	Fresenius Kabi Canada Ltd	Feb 2017
TRAVASOL (500 MG)	00872296	Marketed	Baxter Corporation	Oct 2013
AMINO BOLUSES IMPROVED (525 MG)	00319333	Dormant	Professional Veterinary Laboratories	Oct 2020
AMINOLEAN INJECTION (1.6 MG)	00506990	Dormant	Bimeda-MTC Animal Health Inc.	Jul 2023
AMINOSYN II (530 MG)	00742619	Dormant	Icu Medical Canada Inc	Aug 2018
AMINOSYN II (795 MG)	02126745	Dormant	Icu Medical Canada Inc	Sep 2018
2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE (125 MG)	02143267	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2015
2.5%TRAVASOL AMINO ACID INJ.W.ELEC.W.25%DEX (125 MG)	02143259	Cancelled Post Market	Clintec Nutrition Company	Aug 1998
2.75% TRAVAS. AMINO ACID INJ.W.ELECW.25%DEX (137.5 MG)	02143232	Cancelled Post Market	Clintec Nutrition Company	Aug 1998
2.75%TRAVASOL AMINO ACID INJ.W.ELEC.W.5%DEX. (137.5 MG)	02143240	Cancelled Post Market	Clintec Nutrition Company	Aug 1999
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE (212.5 MG)	02142414	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2015
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE (212.5 MG)	02142406	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2007
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE (212.5 MG)	02142392	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2015
4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTRLYTES IN 10% DEXTROSE (212.5 MG)	02142317	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2015
4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE (212.5 MG)	02142309	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2007
4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 25% DEXTROSE (212.5 MG)	02142295	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2015
4.25%TRAV. AMINO ACID INJ.W.O.ELECT.5%DEXT. (212.5 MG)	02142325	Cancelled Post Market	Clintec Nutrition Company	Aug 1999
4.25%TRAVASOL AMINO ACID INJ.W.ELECW.5%DEX. (212.5 MG)	02143224	Cancelled Post Market	Clintec Nutrition Company	Aug 1999
5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE (250 MG)	02142368	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2015
5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE (250 MG)	02142252	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2015
5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 25% DEXTROSE (250 MG)	02142244	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2007
8.5% FREAMINE III (500 MG)	02158647	Cancelled Post Market	B. Braun Medical AG	Apr 2012
AMINO ACID FORMULA INJ (18.9 MG)	00508365	Cancelled Post Market	Central Sales Limited	Jul 2002
AMINO ACID FORMULA INJ (18.9 MG)	00583537	Cancelled Post Market	Centravet Products	Aug 1996
AMINO ACID INJECTABLE (3.6 MG)	00626368	Cancelled Post Market	Univet Pharmaceuticals Ltd.	Jun 2023
AMINO-JUG (1.6 MG)	02283514	Cancelled Post Market	Wyeth Animal Health, Division Of Wyeth Canada	Jul 2008
AMINOSYN (420 MG)	00454907	Cancelled Post Market	Icu Medical Canada Inc	Jan 2019
AMINOSYN 10% W ELECTROLYTES (420 MG)	00558966	Cancelled Post Market	Abbott Laboratories Co.	Aug 1999
AMINOSYN 3.5% M (147 MG)	00510629	Cancelled Post Market	Abbott Laboratories Co.	Aug 1999
AMINOSYN 5% (210 MG)	00404160	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
AMINOSYN 7% (300 MG)	00523232	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
AMINOSYN 8.5% (370 MG)	00613320	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
AMINOSYN 8.5% INJECTION WITH ELECTROLYTES (370 MG)	00613339	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II 10% WITH ELECTROLYTES (530 MG)	00742651	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
AMINOSYN II 5% INJ (265 MG)	00742643	Cancelled Post Market	Abbott Laboratories Co.	Aug 1999
AMINOSYN II 7% INJECTION (371 MG)	00742635	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
AMINOSYN II 7% M IN 10% DEXTROSE(DUAL CHAMBER) (186 MG)	00742724	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II 7% WITH 10% DEXTROSE (185 MG)	00742740	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II 7% WITH 50% DEXTROSE (185 MG)	00742759	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II 8.5% INJECTION (450 MG)	00742627	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
AMINOSYN II 8.5% M IN 20% DEXTROSE (DUAL CHAMBER) (225 MG)	00742716	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II 8.5% WITH 50% DEXTROSE (225 MG)	00742767	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II IN DEXTROSE INJECTION (265 MG)	00742783	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II IN DEXTROSE INJECTION (225 MG)	00839302	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II IN DEXTROSE INJECTION (225 MG)	00839310	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM (225 MG)	00851531	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM (225 MG)	00851574	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE WITH CALCIUM (185 MG)	00851566	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN-PF 10% (495 MG)	00731366	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
AMINOSYN-PF 7% (347 MG)	00731358	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
CLINIMIX (250 MG)	02142260	Cancelled Post Market	Baxter Corporation	Dec 2022
CLINIMIX (250 MG)	02142279	Cancelled Post Market	Baxter Corporation	Apr 2022
CLINIMIX 2.5% TRAVASOL AA WITHOUT ELECTROLYTES IN 10% DEXTROSE INJEC (125 MG)	02142333	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2007
CLINIMIX E (250 MG)	02142341	Cancelled Post Market	Baxter Corporation	Jun 2018
CLINIMIX E (250 MG)	02142376	Cancelled Post Market	Baxter Corporation	Jun 2022
NUTRINEAL PD4 (51 MG)	02230810	Cancelled Post Market	Baxter Corporation	Nov 2021
OLIMEL 3.3% E (1.30 G)	02352508	Cancelled Pre Market	Baxter Corporation	Oct 2025
OLIMEL 4.4% (1.75 G)	02352524	Cancelled Post Market	Baxter Corporation	Oct 2025
OLIMEL 4.4% E (1.75 G)	02352516	Cancelled Post Market	Baxter Corporation	Oct 2025
PRIMENE 10%-LIQ IV (400 MG)	02161192	Cancelled Post Market	Clintec Nutrition Company	Aug 1998
RENAMIN (AMINO ACIDS) INJECTION (300 MG)	02020564	Cancelled Post Market	Baxter Corporation	May 2011
VAMIN 18 ELECTROLYTE-FREE (450 MG)	02059711	Cancelled Post Market	Fresenius Kabi Ag	Jul 2006
VAMIN N (750 MG)	02065665	Cancelled Post Market	Fresenius Kabi Ag	Jul 2006

Notices of Compliance

Approvals of drug submissions that list it, newest first.

SMOFKABIVEN PERIPHERALMay 13, 2025 · NOC 35359
OLIMEL 3.3% E; OLIMEL 4.4% E; OLIMEL 5.7% E; OLIMEL 7.6% E; PERIOLIMEL 2.5% EMarch 4, 2025 · NOC 34938
OLIMEL 4.4%; OLIMEL 5.7%; OLIMEL 7.6%March 4, 2025 · NOC 34941
CLINIMIX EJuly 19, 2024 · NOC 33675
OLIMEL 4.4%; OLIMEL 5.7%; OLIMEL 7.6%July 19, 2023 · NOC 31273
OLIMEL 3.3% E; OLIMEL 4.4% E; OLIMEL 5.7% E; OLIMEL 7.6% E; PERIOLIMEL 2.5% EJuly 19, 2023 · NOC 31274
CLINIMIX EApril 1, 2022 · NOC 27894
CLINIMIX EApril 1, 2022 · NOC 27896
OLIMEL 3.3% E; OLIMEL 4.4% E; OLIMEL 5.7% E; OLIMEL 7.6% E; PERIOLIMEL 2.5% EApril 19, 2021 · NOC 26092
20% PROSOLApril 13, 2021 · NOC 25647
ESSEPNADecember 30, 2020 · NOC 24899
SMOFKABIVEN ELECTROLYTE FREE; SMOFKABIVEN EXTRA NITROGEN ELECTROLYTE FREEJuly 9, 2020 · NOC 23877
SMOFKABIVEN; SMOFKABIVEN EXTRA NITROGENJuly 9, 2020 · NOC 23882
AMINOSYNMay 31, 2018 · NOC 20928
AMINOSYN IIMay 30, 2018 · NOC 20927
AMINOSYN IIDecember 22, 2017 · NOC 20200
AMINOSYNDecember 22, 2017 · NOC 20201
SMOFKABIVEN PERIPHERALJuly 5, 2016 · NOC 18221
AMINOSYN-PF 10%; AMINOSYN-PF 7%January 7, 2016 · NOC 23269
PRIMENE 10%December 18, 2014 · NOC 16455
CLINIMIX - 4.25% (BLEND B) IN 10%; CLINIMIX - 4.25% (BLEND B) IN 25%; CLINIMIX - 5% (BLEND B) IN 16.6%; CLINIMIX - 5% (BLEND B) IN 10%; CLINIMIX - 5% (BLEND B) IN 5%; CLINIMIX - 5% (BLEND B) IN 20%; CLINIMIX - 5% (BLEND B) IN 25%; CLINIMIX - 5% (BLEND C) IN 10%; CLINIMIX - 5% (BLEND C) IN 16.6%; CLINIMIX E - 4.25% (BLEND B) IN 10%; CLINIMIX E - 4.25% (BLEND B) IN 25%; CLINIMIX E - 5% (BLEND B) IN 10%; CLINIMIX E - 5% (BLEND B) IN 16.6%; CLINIMIX E - 5% (BLEND B) IN 20%; CLINIMIX E - 5% (BLEND B) IN 25%; CLINIMIX E - 5% (BLEND C) IN 10%; CLINIMIX E - 5% (BLEND C) IN 16.6%; CLINIMIX E - 5% (BLEND C) IN 25%June 5, 2014 · NOC 15669
TRAVASOL E; TRAVASOL (BLEND B); TRAVASOL (BLEND C)May 29, 2014 · NOC 15652
AMINOSYN 5%; AMINOSYN 7%; AMINOSYN 8.5%; AMINOSYN 10%February 25, 2014 · NOC 15340
AMINOSYN 8.5% WITH ELECTROLYTESFebruary 25, 2014 · NOC 15342
AMINOSYN-PF 7%; AMINOSYN-PF 7% AND 10%February 25, 2014 · NOC 15343
AMINOSYN II 7%; AMINOSYN II 8.5%; AMINOSYN II 10%; AMINOSYN II 15%February 25, 2014 · NOC 15344
TRAVASOL E; TRAVASOL (BLEND B); TRAVASOL (BLEND C)October 7, 2013 · NOC 14805
AMINOSYN II 10%June 5, 2012 · NOC 13449
OLIMEL 3.3% WITH ELECTROLYTES; OLIMEL 4.4%; OLIMEL 4.4% WITH ELECTROLYTES; OLIMEL 5.7%; OLIMEL 5.75% WITH ELECTROLYTES; PERIOLIMEL 2.5% WITH ELECTROLYTESDecember 22, 2011 · NOC 12890
AMINOSYN II 15% (SULFITE FREE)September 27, 2010 · NOC 11746
PERIOLIMEL 2.5% E; OLIMEL 3.3% WITH ELECTROLYTES; OLIMEL 4.4%; OLIMEL 4.4% WITH ELECTROLYTES; OLIMEL 5.7%; OLIMEL 5.7% WITH ELECTROLYTESJune 28, 2010 · NOC 11567
AMINOSYN II 7%; AMINOSYN II 8.5%; AMINOSYN II 10%June 19, 2009 · NOC 10262
AMINOSYN 8.5% WITH ELECTROLYTESJune 19, 2009 · NOC 10264
AMINOSYN PF 7%; AMINOSYN PF 10%June 19, 2009 · NOC 10265
AMINOSYN 5%; AMINOSYN 7%; AMINOSYN 8.5%; AMINOSYN 10%June 19, 2009 · NOC 10266
AMINOSYN II 10%; AMINOSYN II 15%June 6, 2008 · NOC 9590
AMINOSYN 8.5% INJ WITH ELECTROLYTESJanuary 26, 2006 · NOC 7710
AMINOSYN II 7% M IN 10% DEXTROSE (DUAL CHAMBER); AMINOSYN II 8.5% M IN 20% DEXTROSE (DUAL CHAMBER)June 8, 2004 · NOC 3768
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE WITH CALCIUMJune 8, 2004 · NOC 3769
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE WITH CALCIUMJune 8, 2004 · NOC 3773
AMINOSYN II 10% WITH ELECTROLYTESJune 8, 2004 · NOC 3774
AMINOSYN-PF 7%; AMONISYN-PF 10%June 8, 2004 · NOC 3776
AMINOSYN II 10%; AMINOSYN II 15%June 8, 2004 · NOC 3777
AMINOSYN II 7%; AMINOSYN II 8.5%; AMINOSYN II 10%June 8, 2004 · NOC 3778
AMINOSYN 5%; AMINOSYN 7%; AMINOSYN 8.5%; AMINOSYN 10%June 8, 2004 · NOC 3779
AMINOSYN II 7% WITH 10% DEXTROSE; AMINOSYN II 7% WITH 50% DEXTROSE; AMINOSYN II 8.5% WITH 50% DEXTROSEJune 4, 2004 · NOC 4274
AMINOSYN II 10% WITH 50% DEXTROSEJune 4, 2004 · NOC 4277
AMINOSYN II 4.25% WITH 10% DEXTROSE; AMINOSYN II 4.25% WITH 20% DEXTROSEJune 4, 2004 · NOC 4280
20% PROSOLOctober 30, 2001 · NOC 2209
TRAVASOL 20% - LIQ IVApril 6, 1999 · NOC 1843
VAMIN 14; VAMIN 14 ELECTROLYTE FREE; VAMIN 18 ELECTROLYTE FREESeptember 4, 1997 · NOC 6023
VAMIN NSeptember 4, 1997 · NOC 6024
NUTRINEAL PD4February 27, 1997 · NOC 3275
TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES AND DEXTROSEJanuary 30, 1996 · NOC 6042
TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES AND DEXTROSEJanuary 30, 1996 · NOC 6043
TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES AND WITH DEXTROSEJanuary 30, 1996 · NOC 6075
TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES AND WITH DEXTROSEJanuary 30, 1996 · NOC 6076
TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES WITH DEXTROSENovember 25, 1994 · NOC 5954
TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES WITH DEXTROSENovember 21, 1994 · NOC 5955
AMINOSYN II (15%)August 25, 1994 · NOC 5163
VAMIN NApril 20, 1994 · NOC 5956
VAMIN NJanuary 14, 1994 · NOC 5899